Talk:Valganciclovir

Wiki Education Foundation-supported course assignment
This article is or was the subject of a Wiki Education Foundation-supported course assignment. Further details are available on the course page. Student editor(s): Bsalce, Swani8, Gloring14, Stephanie.eg. Peer reviewers: Jborbon, Iaminwillmart, Rahatm786, Ktham.

Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 12:14, 17 January 2022 (UTC)

Group 29 Edit Plan
1. Mechanism of Action 2. Toxicity 3. Drug Interaction 4. Clinical Use

We will use PubMed to update this section.

(Glori Wai, Brandon Salce, Sarita Wanichpan, Stephanie Roman)

PEER REVIEW FROM GROUP 30:

STUDENT 1 – Does the draft submission reflect a neutral point of view? If not, specify…
 * I believe most of the statements themselves are written neutrally, but question the neutrality of the Research section in that it is quoting only one trial's results about a controversial syndrome in itself (chronic fatigue). Although not the focus of my class assignment question, I will also point out the pharmacokinetics are all already available in the right-hand side's chembox so I'm not sure if it should be an article section. Stevenwsamuels (talk) 08:11, 15 November 2016 (UTC)

STUDENT 2 – Are the points included verifiable with cited secondary sources that are freely accessible? If not, specify… It seems that most of the sources cited are freely accessible. The journal articles used to cite the Wiki page were predominantly found on Pubmed. However, I did not that reference 11 directs readers to a site that no longer exists. The reference was used to cite the statement, "The price of a four-month course of valganciclovir from Roche is about US$8,500 in high-income countries, $6,000 in India. However, the valganciclovir patent was rejected by the Indian Patent Office[11] in 2010, although Roche may appeal the rejection." It might be possible to leave this statement out, if a new linked is not found. jborbon STUDENT 3 – Are the edits formatted consistent with Wikipedia’s manual of style for medicine-related articles? If not, specify…
 * The titles are clear and recognizable to the reader. However, there are some inconsistencies in terms of the first letter being capitalized in the title (see “Use in Pediatric Patients” vs. “Side effects”). Some of the titles have the first letter capitalized for all the words in the title whereas some titles do not. In the research section there is an innapropirate semicolon in the last paragraph. Overall, I would say that this article is consistent with Wikipedia’s manual of style for medicine-related articles and presents an article that is user friendly, and easy to read for non-health professionals. 128.218.43.142 (talk) 20:02, 15 November 2016 (UTC)

STUDENT 4 – Is there any evidence of plagiarism or copyright violation? If yes, specify…
 * The majority of the article looks free from plagiarism or copyright violation. One area I would be sure to include citations for is the pharmacokinetics section. One more edit I think would be beneficial is to change the wording (in the last paragraph of the Research section from "In a free preview of ....." to something with the title of the article in it "Valganciclovir for Symptomatic Congenital Cytomegalovirus Disease" Iaminwillmart (talk) 18:09, 15 November 2016 (UTC)